Molecular target therapy cancer

Reubi, J. C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocrinol. Rev. 24 389MZ7,2003. 

Wallace EM, LyssikatosJ, Blake JF, Seo J, YangHW, Yeh TC, Perrier M, Jarski H, Marsh V, Poch G, Goyette Livingston M, Otten J, Hingorani G, Woessner R, Win-ski SL, Anderson DA, Lee P, Winkler J, Koch K (2005) Abstracts of the AACR-NCl-EORTC International Conference on Molecular Targets and Cancer Therapy, Philadelphia, 14-18 Nov 2005 Abstr B77... 

Haber DA, Bell DW, Sordella R et al. Molecular targeted therapy of lung cancer EGFR mutations and response to EGFR inhibitors. Cold Spring Harb Symp Quant Biol 2005 70 419-426. 

Deininger MW. Basic science going clinical molecularly targeted therapy of chronic myelogenous leukemia. J Cancer Res Clin Oncol 2004 130 59-72. 

Espina V, Geho D, Mehta AI et al. Pathology of the future molecular profiling for targeted therapy. Cancer Invest 2005 23 36 6. 

Kaelin WG Jr. Taking aim at novel molecular targets in cancer therapy. J. Clin. Invest. 1999104 1495. 

Rosa DD, Ismael G, Lago LD, et al. Molecular-targeted therapies Lessons from years of clinical development. Cancer Treat Rev. 2008 34(l) 61-80. 

Widakowich C, de Castro G, de Azambuja E, Dinh P, Awada A (2007) Review Side effects of approved molecular targeted therapies in solid cancers. Oncologist 12 1443-1455... 

Abnormal activation of specific protein tyrosine kinases has been demonstrated in many human neoplasms, making them attractive molecular targets for cancer therapy. There currently are 3 smaU-molecular-weight protein tyrosine kinase inhibitors that are FDA-approved and many others in clinical trials. 

Becker JC, Kirkwood JM, Agarwala SS, Dummer R, Schrama D, Hauschild A. Molecularly targeted therapy for melanoma current reality and future options. Cancer 2006 107 2317-27. 

Lung cancer is a leading cause of cancer deaths worldwide, and the outcome of treatment has not significantly improved for decades. There is strong interest in molecularly targeted therapy for lung cancer in hope to... 

Reubi, J.C. Landolt, A.M. (1984) High density of somatostatin receptors in pituitary tumors from acromegalic patients.. Clin. Endocrinol Metab, Vol. 59, pp. 1148-1151. Reubi, J.C. (2003) Peptide receptors as molecular targets for cancer diagnosis and therapy Endocr. Rev., Vol. 24, No. 4, pp. 389-427. 

Pennington, J.D., Wang, T.J., Nguyen, P, Sun, L., Bisht, K., Smart, D., and Gius, D. (2005). Redox-sensitive signaling factors as a novel molecular targets for cancer therapy. Drug Resist. Updat. S, 322-330. 

---